-
W. P. Carey (WPC) Reports In-Line Q3 EPS
-
Rockwell Medical (RMTI)
-
W. P. Carey (WPC) Declares $0.910 Quarterly Dividend; 5.4% Yield
-
Wells Fargo Upgrades W. P. Carey & Co. (WPC) to Overweight
-
W. P. Carey reports $1.3 billion in year-to-date investments
-
W. P. Carey (WPC) Misses Q2 EPS by 40c; raises guidance
-
Citizens JMP Reiterates Market Perform Rating on W. P. Carey & Co. (WPC)
-
W. P. Carey (WPC) prices $400 million senior notes offering due 2030
-
W. P. Carey (WPC) Declares $0.90 Quarterly Dividend; 5.7% Yield
-
Citizens JMP Reiterates Market Perform Rating on W. P. Carey & Co. (WPC)
-
W. P. Carey (WPC) Misses Q1 EPS by 4c
-
Citizens JMP Reiterates Market Perform Rating on W. P. Carey & Co. (WPC)
-
W. P. Carey (WPC) Provides Business Update
-
W. P. Carey (WPC) Releases 2024 CEO Letter
-
W. P. Carey (WPC) Raises Quarterly Dividend 1.1% to $0.89; 5.8% Yield
-
W. P. Carey & Co. (WPC) PT Raised to $63 at Scotiabank
-
W. P. Carey & Co. (WPC) PT Raised to $64 at Evercore ISI
-
BMO Capital Upgrades W. P. Carey & Co. (WPC) to Outperform, 'Getting Its Groove Back'
-
W. P. Carey (WPC) Misses Q4 EPS by 33c, provides guidance
-
Modiv (MDV) Announces Latest Portfolio Appraisal
-
Barclays Assumes W. P. Carey & Co. (WPC) at Underweight
-
W. P. Carey (WPC) Declares $0.880 Quarterly Dividend; 6.3% Yield
-
W. P. Carey (WPC) Prices EUR 600M Notes Offering
-
These are four bull stocks according to BofA analysts, plus two bears
-
W. P. Carey (WPC) Misses Q3 EPS by 3c; offers guidance
-
W. P. Carey & Co. (WPC) PT Raised to $70 at JPMorgan
-
W. P. Carey (WPC) Declares $0.875 Quarterly Dividend; 5.5% Yield
-
W. P. Carey & Co. (WPC) PT Lowered to $62 at RBC Capital
-
W. P. Carey (WPC) Tops Q2 EPS by 6c; lowers guidance
-
W. P. Carey (WPC): John Park will step down as President
-
Citi Reiterates Neutral Rating on W. P. Carey & Co. (WPC)
-
W. P. Carey (WPC) Prices $400M Notes Offering
-
W. P. Carey (WPC) Declares $0.870 Quarterly Dividend; 6.2% Yield

